Default: Journal of Hematology and Oncology

ISSN:

Journal Home

Journal Guideline

Journal of Hematology and Oncology Q1 Unclaimed

BioMed Central Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Hematology and Oncology is a journal indexed in SJR in Molecular Biology and Hematology with an H index of 144. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1815 €. The scope of the journal is focused on haematology, oncology. It has an SJR impact factor of 7,522 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 7,522.

Journal of Hematology and Oncology focuses its scope in these topics and keywords: biomarkers, progression, pathwayssmi, pathways, pathogenesis, nsclc, nktldownstream, natural, myeloid, proliferative, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

1815 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Journal of Hematology and Oncology

7,522

SJR Impact factor

144

H Index

115

Total Docs (Last Year)

531

Total Docs (3 years)

11441

Total Refs

12065

Total Cites (3 years)

413

Citable Docs (3 years)

20.83

Cites/Doc (2 years)

99.49

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


biomarkers, progression, pathwayssmi, pathways, pathogenesis, nsclc, nktldownstream, natural, myeloid, proliferative, signaling, tumors, therapeutic, t, suppresses, statusimmunotherapy, srcrelated, src, spectrum, multiple, molecular, modulating, differentiation, bcl, biology, cell, flt, genitourinary, implicationsac, inhibitor, iodide, irrespective, killer, leukemia, leukemiapathogenesis, lymphoid, lymphoma, malignancies, haematology, oncology



Best articles by citations

Ferroptosis, a new form of cell death: opportunities and challenges in cancer

Yanhua Mou Jun Wang Jinchun Wu
1081 Citations View more

Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications

Yuxin Lin Jianxin Xu Huiyin Lan
911 Citations View more

The biology and role of CD44 in cancer progression: therapeutic implications

Chen Chen Shujie Zhao Anand Karnad
833 Citations View more

Ferroptosis, necroptosis, and pyroptosis in anticancer immunity

Rong Tang Jin Xu Bo Zhang
772 Citations View more

Nanomaterials for cancer therapy: current progress and perspectives

Zhe Cheng Maoyu Li Raja Dey
624 Citations View more

Tumor-associated macrophages: from basic research to clinical application

Li Yang Yi Zhang
621 Citations View more

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Xinyuan Li Pu Fang Jietang Mai
587 Citations View more

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

Tongyan Liu Chencheng Han Siwei Wang
583 Citations View more

Exosomes in cancer: small particle, big player

Xu Zhang Xiao Yuan Hui Shi
580 Citations View more

Targeting mTOR for cancer therapy

Hui Hua Qingbin Kong Hongying Zhang
574 Citations View more

Next generation of immune checkpoint therapy in cancer: new developments and challenges

Julian A. Marin-Acevedo Bhagirathbhai Dholaria Aixa E. Soyano
566 Citations View more

Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma

Guohua Lou Xiuli Song Fan Yang
528 Citations View more
SHOW MORE ARTICLES

EZH2: a novel target for cancer treatment

Ran Duan Wenfang Du Weijian Guo
527 Citations View more

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

Si Zhang Yangyang Liu Xiaofang Wang
500 Citations View more

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

Akintunde Akinleye Zoaib Rasool
487 Citations View more

Wnt/beta-catenin pathway: modulating anticancer immune response

Sachin Gopalkrishna Pai Benedito A. Carneiro Jose Mauricio Mota
468 Citations View more

Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer

Senlin Zhao Yushuai Mi Bingjie Guan
430 Citations View more

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Pengfei Zhao Li Li Xiaoyue Jiang
423 Citations View more

Role of platelets and platelet receptors in cancer metastasis

Martin Schlesinger
406 Citations View more

The interplay between m6A RNA methylation and noncoding RNA in cancer

Shuai Ma Chen Chen Xiang Ji
402 Citations View more

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Wan-Hong Zhao Jie Liu Bai-Yan Wang
380 Citations View more

NK cell-based cancer immunotherapy: from basic biology to clinical development

Sizhe Liu Vasiliy Galat Yekaterina Galat4
376 Citations View more

Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development

Guoshuang Shen Fangchao Zheng Dengfeng Ren
357 Citations View more

FAQS